Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Nivolumab
Relatlimab
Locations
3
United States
Johns Hopkins University
Baltimore, Maryland, United States
Alleghany Health Network
Pittsburgh, Pennsylvania, United States
Baylor University
Dallas, Texas, United States
Start Date
March 6, 2019
Primary Completion Date
April 1, 2026
Completion Date
December 1, 2026
Last Updated
December 22, 2025
NCT06257264
NCT06253871
NCT05431738
NCT05438940
NCT05632939
NCT04164979
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions